Late Breaking Abstract - ELEVATE IPF phase 2b open-label extension demonstrates durable efficacy of deupirfenidone - Amsterdam 2025

Clinical and translational advances in ultra-rare lung diseases

Chair(s): Nishant Gupta, Marissa O'Callaghan

Session type: Oral presentation

Late Breaking Abstract - ELEVATE IPF phase 2b open-label extension demonstrates durable efficacy of deupirfenidone

ARGYRIS TZOUVELEKIS

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - ELEVATE IPF phase 2b open-label extension demonstrates durable efficacy of deupirfenidone

Argyris Tzouvelekis

Replay

Poster

Abstract

Slides

When to test for Birt-Hogg-Dubé Syndrome? UK national data

Froher Yasin

Replay

Poster

Abstract

Slides

Genetic Predictors of Pneumothorax in Birt-Hogg-Dubé Syndrome

Marie Moldt Holmager

Replay

Poster

Abstract

Slides

Blood cytokines and chemokines in adult pulmonary langerhans cell histiocytosis and their association with FEV1 evolution

Amira Benattia

Replay

Poster

Abstract

Slides

Implications of iron metabolism dysregulation for diagnosis and treatment of pulmonary lymphangioleiomyomatosis

Min Xie

Replay

Poster

Abstract

Slides

Differentiating diffuse cystic lung disease from emphysema using machine learning techniques

Donal O'malley

Replay

Poster

Abstract

Slides

Fully automatic quantification of pulmonary fat attenuation volume by CT: an exploratory pilot study in non-malignant chronic lung diseases.

Francesco Bonella

Replay

Poster

Abstract

Slides

Pulmonary Fibrosis in Pulmonary Alveolar Proteinosis (PAP): A Multi-centre Computed Tomography (CT) Analysis

Niamh Boyle

Replay

Abstract

Slides

Advanced Strategies for Detecting Acid Sphingomyelinase Deficiency Type B with Attenuated Phenotypes

Thomas Villeneuve

Replay

Poster

Abstract

Slides

Genetic and clinical characteristics of familial pulmonary fibrosis patients and relatives

Nathalie Veyt

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}